Corpus ID: 38595970

TGF-beta/Smad signaling in the injured liver.

  title={TGF-beta/Smad signaling in the injured liver.},
  author={K. Breitkopf and P. Godoy and L. Ciuclan and M. Singer and S. Dooley},
  journal={Zeitschrift fur Gastroenterologie},
  volume={44 1},
TGF-beta, acting both directly and indirectly, represents a central mediator of fibrogenic remodeling processes in the liver. Besides hepatic stellate cells (HSCs), which are induced by TGF-beta to transdifferentiate to myofibroblasts and to produce extracellular matrix, hepatocytes are also strongly responsive for this cytokine, which induces apoptosis during fibrogenesis and provides growth control in regeneration processes. Based on this, TGF-beta-mediated hepatic responses to injury are the… Expand
TGF-β Signaling in Onset and Progression of Hepatocellular Carcinoma
In order to achieve therapeutic effects, targeting TGF-β signaling in the right cell type at the right time is required and activation of survival signaling pathways in hepatocytes as a most critical requirement is identified. Expand
TGF-beta signaling in alcohol induced hepatic injury.
Findings challenge the current view of the passive role of hepatocytes in liver fibrosis, as hepatocyte-specific inhibition of the TGF-beta pathway prevents CCl4 induced liver injury. Expand
Rap1 regulates hepatic stellate cell migration through the modulation of RhoA activity in response to TGF-β1
It is suggested that TGF-β1 regulates Rap1, resulting in the suppression of RhoA, activation of and formation of F-actin during the migration of HSCs. Expand
An attempt has been madeto add a drop of knowledge in the sea of already available literature on liver fibrosis in order to elaborate the role of hepatic stellate cellsliver fibrosis, its activation, some of the signaling pathways implicated in its activation. Expand
Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.
Hic-5 deficiency attenuates the activation of HSCs and liver fibrosis though reducing the TGF-β/Smad2 signaling by upregulation of Smad7, and can be regarded as a potential therapeutic target for liver Fibrosis. Expand
Abrogation of ALK5 in hepatic stellate cells decreases hepatic fibrosis and ameliorates liver damage in mice following treatment with thioacetamide
It is reported that abrogation of TGF-β type I receptor ALK5 in HSC activation led to reduced collagen deposition and a decreased number of myofibroblasts in livers of mutant mice lacking ALK 5 in H SC (Alk5/GFAP-Cre mice) following thioacetamide (TAA) exposure. Expand
Mechanisms of hepatic stellate cell activation
These findings reinforce the remarkable complexity and plasticity of HSC activation, and underscore the value of clarifying its regulation in hopes of advancing the development of novel diagnostics and therapies for liver disease. Expand
CXCL6‐EGFR‐induced Kupffer cells secrete TGF‐β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C‐MYC/EZH2 pathway in liver fibrosis
  • Xiaobo Cai, Z. Li, +4 authors L. Lu
  • Chemistry, Medicine
  • Journal of cellular and molecular medicine
  • 2018
The results reveal that CXCL6 plays an important role in liver fibrosis through stimulating the release of TGF‐β by KCs and thereby activating HSCs. Expand
Mechanisms of hepatic fibrogenesis.
Clinical and translational implications of these advances have become clear, and have begun to impact significantly on the management and outlook of patients with chronic liver disease. Expand
A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response
An intersecting VDR/SMAD genomic circuit that regulates hepatic fibrogenesis is revealed and a role for VDR as an endocrine checkpoint to modulate the wound-healing response in liver is defined. Expand